These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18784686)

  • 1. Cancer complexity slows quest for cure.
    Check Hayden E
    Nature; 2008 Sep; 455(7210):148. PubMed ID: 18784686
    [No Abstract]   [Full Text] [Related]  

  • 2. miRNA-Based Technologies in Cancer Therapy.
    Pagoni M; Cava C; Sideris DC; Avgeris M; Zoumpourlis V; Michalopoulos I; Drakoulis N
    J Pers Med; 2023 Nov; 13(11):. PubMed ID: 38003902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions.
    Erfanparast L; Taghizadieh M; Shekarchi AA
    Front Oncol; 2022; 12():914593. PubMed ID: 35898889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Effects of Mitochondria-Targeted Antioxidants in a Small-Cell Carcinoma of the Ovary of Hypercalcemic Type and in Type 1 and Type 2 Endometrial Cancer.
    Castelôa M; Moreira-Pinto B; Benfeito S; Borges F; Fonseca BM; Rebelo I
    Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.
    Raue R; Frank AC; Syed SN; Brüne B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of MicroRNAs as Potential Therapeutics against Cancer.
    Abd-Aziz N; Kamaruzman NI; Poh CL
    J Oncol; 2020; 2020():8029721. PubMed ID: 32733559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Products and Synthetic Analogs as a Source of Antitumor Drugs.
    Sharifi-Rad J; Ozleyen A; Boyunegmez Tumer T; Oluwaseun Adetunji C; El Omari N; Balahbib A; Taheri Y; Bouyahya A; Martorell M; Martins N; Cho WC
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31683894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo.
    Wach S; Brandl M; Borchardt H; Weigelt K; Lukat S; Nolte E; Al-Janabi O; Hart M; Grässer F; Giedl J; Jung R; Stöhr R; Hartmann A; Lieb V; Höbel S; Peters A; Stäubert C; Wullich B; Taubert H; Aigner A
    Mol Ther Nucleic Acids; 2019 Jun; 16():272-283. PubMed ID: 30933831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marine drugs for cancer: surfacing biotechnological innovations from the oceans.
    Jimenez PC; Wilke DV; Costa-Lotufo LV
    Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e482s. PubMed ID: 30133563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective on the dynamics of cancer.
    Derbal Y
    Theor Biol Med Model; 2017 Oct; 14(1):18. PubMed ID: 28969664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.
    Yamamoto Y; Hyodo I; Koga Y; Tsumura R; Sato R; Obonai T; Fuchigami H; Furuya F; Yasunaga M; Harada M; Kato Y; Ohtsu A; Matsumura Y
    Cancer Sci; 2015 May; 106(5):627-34. PubMed ID: 25711681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses for tumor therapy.
    Bell J; McFadden G
    Cell Host Microbe; 2014 Mar; 15(3):260-5. PubMed ID: 24629333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function.
    Tomasetti M; Nocchi L; Staffolani S; Manzella N; Amati M; Goodwin J; Kluckova K; Nguyen M; Strafella E; Bajzikova M; Peterka M; Lettlova S; Truksa J; Lee W; Dong LF; Santarelli L; Neuzil J
    Antioxid Redox Signal; 2014 Nov; 21(15):2109-25. PubMed ID: 24444362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Error-promoting DNA synthesis in ovarian cancer cells.
    Dai H; Hickey RJ; Liu J; Bigsby RM; Lanner C; Malkas LH
    Gynecol Oncol; 2013 Oct; 131(1):198-206. PubMed ID: 23851291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving cancer therapy by combining cell biological, physical, and molecular targeting strategies.
    Nickoloff JA
    Chin J Cancer Res; 2013 Feb; 25(1):7-9. PubMed ID: 23372336
    [No Abstract]   [Full Text] [Related]  

  • 16. Tailored immunoconjugate therapy depending on a quantity of tumor stroma.
    Yasunaga M; Manabe S; Tarin D; Matsumura Y
    Cancer Sci; 2013 Feb; 104(2):231-7. PubMed ID: 23121194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promises and challenges of MicroRNA-based treatment of multiple myeloma.
    Tagliaferri P; Rossi M; Di Martino MT; Amodio N; Leone E; Gulla A; Neri A; Tassone P
    Curr Cancer Drug Targets; 2012 Sep; 12(7):838-46. PubMed ID: 22671926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of substitution, deletion and insertion mutations in cancer genes.
    Iengar P
    Nucleic Acids Res; 2012 Aug; 40(14):6401-13. PubMed ID: 22492711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What does physics have to do with cancer?
    Michor F; Liphardt J; Ferrari M; Widom J
    Nat Rev Cancer; 2011 Aug; 11(9):657-70. PubMed ID: 21850037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing therapeutic microRNAs for cancer.
    Bader AG; Brown D; Stoudemire J; Lammers P
    Gene Ther; 2011 Dec; 18(12):1121-6. PubMed ID: 21633392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.